Effect of Anticholinergic Drug On uroflowmetry
Phase 3
- Conditions
- Benign Prostatic Hyperplasia.Enlarged prostate
- Registration Number
- IRCT20190928044913N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Patient Whit Benign Prostatic Hyperplasia treat with a Blaker
Exclusion Criteria
Past Mediacal History of Prostatic cancer
Age underb 50 years
Past Medical History Prostatic surgery
Past Medical History Of neurology illness
History Of Use Anticholinergic In 2 Past Week
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Q max in uroflowmetry. Timepoint: at begening and 1 month later. Method of measurement: uroflowmetri.
- Secondary Outcome Measures
Name Time Method rine rezidual. Timepoint: at beginnig and 1 month later. Method of measurement: sonography.;Prostate volume. Timepoint: at beginning and 1 month later. Method of measurement: sonography.